首页 中华结核和呼吸杂志 2015年38卷5期 无创气道炎症评估支气管哮喘的临床应用中国专家共识
中华结核和呼吸杂志
期刊首页
过刊列表
高级检索
稿件发表
• 诊疗方案 •
无创气道炎症评估支气管哮喘的临床应用中国专家共识
中国医师协会呼吸医师分会
作者及单位信息
·
DOI: 10.3760/cma.j.issn.1001-0939.2015.05.004
5726
1893
5
0
15
3
扫描转手机阅读
下载中华医学期刊APP阅读更流畅 体验更丰富
PDF下载
APP内阅读
引用本文
中国医师协会呼吸医师分会. 无创气道炎症评估支气管哮喘的临床应用中国专家共识[J]. 中华结核和呼吸杂志,2015,38(5):329-341.
DOI:10.3760/cma.j.issn.1001-0939.2015.05.004PERMISSIONS
Request permissions for this article from CCC.
评价本文
*以上评分为匿名评价
本文评分
0分
[累计0个]
向我们报错
版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。
除非特别声明,本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。
支气管哮喘(哮喘)最重要的病理学改变是气道的慢性炎症,而气道炎症水平与气道高反应性密切相关,是出现临床症状的根本原因
[
1
]。因此,气道炎症的评估,特别是无创气道炎症评估方法的发展和临床应用,对于更加深入了解哮喘的病理生理改变和特征,指导哮喘的管理,更好地达到哮喘的总体控制目标有着重要的意义
[
2
]。
中国医师协会呼吸医师分会和中国哮喘联盟组织有关专家进行了认真的讨论,并参照国际相关指南以及近年国内外发表的重要文献
[
3
,
4
],撰写了本共识,希望能在无创气道炎症评估方法,特别是呼出气一氧化氮(fractional exhaled nitric oxide,FeNO)检测的方法学、质量控制、结果判读以及临床应用等方面提出指导意见,以达到更好应用该项技术,指导临床应用的目的。关于FeNO检测的临床意义和使用价值尚有诸多有待探索的地方,本共识也提出了存在的问题和未来研究的方向,期待我国哮喘防治工作者予以关注,结合我国实际情况开展临床研究,特别是多中心协作研究,以提高我国在该领域的临床应用和研究水平。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
已是订阅账户?
登录
参考文献
[1]
中华医学会呼吸病学分会哮喘学组. 支气管哮喘控制的中国专家共识[J]. 中华内科杂志, 2013,52(5):440–443.
[2]
林江涛. 达到哮喘总体控制是实施有效哮喘管理的核心[J]. 中华内科杂志, 2014,53(8):594–595.
[3]
Dweik RA , Boggs PB , Erzurum SC ,et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications[J]. Am J Respir Crit Care Med, 2011,184(5):602–615.
[4]
Bjermer L , Alving K , Diamanta Z ,et al. Current evidence and future research needs for FeNO measurement in respiratory diseases[J]. Respiratory Medicine, 2014,108(6):830–841.
[5]
中华医学会呼吸病学分会肺功能专业组. 肺功能检查指南(第三部分)——组织胺和乙酰甲胆碱支气管激发试验[J]. 中华结核和呼吸杂志, 2014,37(8):566–571.
[6]
张皓,邬宇芬,黄剑锋,等. 儿童肺功能检测及评估专家共识[J]. 临床儿科杂志, 2014,32(2):104–114.
[7]
郑劲平,陈荣昌. 支气管激发试验检查/肺功能学-基础与临床[M]. 广东:广东科技出版社, 2007:93–115.
[8]
中华医学会呼吸病学分会. 气道反应性测定方法(支气管激发试验)[J]. 中华结核和呼吸杂志, 1997,20(5):265–267.
[9]
Mochizuki H , Arukawa H , Tokuyama K ,et al. Bronchial sensitivity and bronchial reactivity in children with cough variant asthma[J]. Chest, 2005,128(4):2427–2434.
[10]
Gibson PG . How to measure airway inflammation: induced sputum[J]. Can Respir J, 1998,5Suppl A:22A–26A.
[11]
Simpson JL , McElduff P , Gibson PG . Assessment and reproducibility of non-eosinophilic asthma using induced sputum[J]. Respiration, 2010,79(2):147–151.
[12]
中华医学会呼吸病学分会哮喘学组. 咳嗽的诊断与治疗指南[J]. 中华结核和呼吸杂志, 2009,32(6):407–413.
[13]
Wark PA , Gibson PG , Fakes K . Induced sputum eosinophils in the assessment of asthma and chronic cough[J]. Respirology, 2000,5(1):51–57.
[14]
Kharitonov S , Alving K , Barnes PJ . Exhaled and Hasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force[J]. Eur Respir J, 1997,10(7):1683–1693.
[15]
American Thoracic Society,European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005[J]. Am J Respir Crit Care Med, 2005,171(8):912–930.
[16]
National Institute for Health and Care Excellence. Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath[J]. http://www.nice.org.uk/guidance/dg12.
[17]
Taylor DR , Pijnenburg MW , Smith AD ,et al. Exhaled nitric oxide measurements: clinical application and interpretation[J]. Thorax, 2006,61(9):817–827.
[18]
Columbo M , Wong B , Panettieri RA Jr,et al. Asthma in the elderly: the role of exhaled nitric oxide measurements[J]. Respir Med, 2013,107(5):785–787.
[19]
Spitale N , Popat N , McIvor A . Update on exhaled nitric oxide in pulmonary disease[J]. Expert Rev Respir Med, 2012,6(1):105–115.
[20]
Robroeks C , van de Kant KDG , Jobsis Q ,et al. Exhaled nitric oxide and biomarkers in exhaled breath condensate indicate the presence, severity and control of childhood asthma[J]. Clin Exp Allergy, 2007,37(9):1303–1311.
[21]
Teng Y , Sun P , Zhang J ,et al. Hydrogen peroxide in exhaled breath condensate in patients with asthma: a promising biomarker?[J]. Chest, 2011,140(1):108–116.
[22]
Baraldi E , Ghiro L , Piovan V ,et al. Increased exhaled 8-isoprostane in childhood asthma[J]. Chest, 2003,124(1):25–31.
[23]
Kielbasa B , Moeller A , Sanak M ,et al. Eicosanoids in exhaled breath condensates in the assessment of childhood asthma[J]. Pediatr Allergy Immunol, 2008,19(7):660–669.
[24]
Shahid SK , Kharitonov SA , Wilson NM ,et al. Exhaled 8-isoprostane in childhood asthma[J]. Respir Res, 2005,6:79.
[25]
Baraldi E , Carraro S , Alinovi R ,et al. Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations[J]. Thorax, 2003,58(6):505–509.
[26]
Zanconato S , Carraro S , Corradi M ,et al. Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma[J]. J Allergy Clin Immunol, 2004,113(2):257–263.
[27]
Mondino C , Ciabattoni G , Koch P ,et al. Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children[J]. J Allergy Clin Immunol, 2004,114(4):761–767.
[28]
Ratnawati , Morton J , Henry RL ,et al. Exhaled breath condensate nitrite/nitrate and pH in relation to pediatric asthma control and exhaled nitric oxide[J]. Pediatr Pulmonol, 2006,41(10):929–936.
[29]
Carpagnano GE , Barnes PJ , Francis J ,et al. Breath condensate pH in children with cystic fibrosis and asthma: a new noninvasive marker of airway inflammation?[J]. Chest, 2004,125(6):2005–2010.
[30]
Steiss JO , Rudloff S , Landmann E ,et al. Effect of inhaled corticosteroid treatment on exhaled breath condensate leukotriene E(4) in children with mild asthma[J]. Allergy Asthma Proc, 2008,29(4):371–375.
[31]
Lex C , Zacharasiewicz A , Payne DNR ,et al. Exhaled breath condensate cysteinyl leukotrienes and airway remodeling in childhood asthma: a pilot study[J]. Respir Res, 2006,7:63.
[32]
Nicolaou NC , Lowe LA , Murray CS ,et al. Exhaled breath condensate pH and childhood asthma: unselected birth cohort study[J]. Am J Respir Crit Care Med, 2006,174(3):254–259.
[33]
Vlasic Z , Dodig S , Cepelak I ,et al. Iron and ferritin concentrations in exhaled breath condensate of children with asthma[J]. J Asthma, 2009,46(1):81–85.
[34]
Thomas PS , Lowe AJ , Samarasinghe P ,et al. Exhaled breath condensate in pediatric asthma: promising new advance or pouring cold water on a lot of hot air? A systematic review[J]. Pediatr Pulmonol, 2013,48(5):419–442.
[35]
Zhang X , Simpson JL , Powell H ,et al. Full blood count parameters for the detection of asthma inflammatory phenotypes[J]. Clin Exp Allergy, 2014,44(9):1137–1145.
[36]
Katz LE , Gleich GJ , Hartley BF ,et al. Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma[J]. Ann Am Thorac Soc, 2014,11(4):531–536.
[37]
Spector SL , Tan RA . Is a single blood eosinophil count a reliable marker for "eosinophilic asthma?"[J]. J Asthma, 2012,49(8):807–810.
[38]
Abd El-Motaleb GS , Abou Amer AA , Elawa GM ,et al. Study of urinary leukotriene E4 levels in children with acute asthma[J]. Int J Gen Med, 2014,7:131–135.
[39]
Rabinovitch N , Graber NJ , Chinchilli VM ,et al. Urinary leukotriene E4/exhaled nitric oxide ratio and montelukast response in childhood asthma[J]. J Allergy Clin Immunol, 2010,126(3):545–551.
[40]
Parulekar AD , Atik MA , Hanania NA . Periostin, a novel biomarker of TH2-driven asthma[J]. Curr Opin Pulm Med, 2014,20(1):60–65.
[41]
Wedes SH , Wu W , Comhair SA ,et al. Urinary bromotyrosine measures asthma control and predicts asthma exacerbations in children[J]. J pediatrics, 2011,159(2):248–255.
[42]
Ferrini ME , Simons BJ , Bassett DJ ,et al. S-nitrosoglutathione reductase inhibition regulates allergen-induced lung inflammation and airway hyperreactivity[J]. PloS one, 2013,8(7):e70351.
[43]
Basu S . Bioactive eicosanoids: role of prostaglandin F(2alpha) and F(2)-isoprostanes in inflammation and oxidative stress related pathology[J]. Molecules and cells, 2010,30(5):383–391.
[44]
Morris CR . Arginine and asthma[J]. Nestle Nutr Inst Workshop Ser, 2013,77:1–15.
[45]
Sy HY , Ko FW , Chu HY ,et al. Asthma and bronchodilator responsiveness are associated with polymorphic markers of ARG1, CRHR2 and chromosome 17q21[J]. Pharmacogenet Genomics, 2012,22(7):517–524.
[46]
Smith AD , Cowan JO , Filsell S ,et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests[J]. Am J Respir Crit Care Med, 2004,169(4):473–478.
[47]
Berkman N , Avital A , Breuer R ,et al. Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests[J]. Thorax, 2005,60(5):383–388.
[48]
Matsunaga K , Hirano T , Akamatsu K ,et al. Exhaled nitric oxide cutoff values for asthma diagnosis according to rhinitis and smoking status in Japanese subjects[J]. Allergol Int, 2011,60(3):331–337.
[49]
任旭斌,刘春涛,黄玉芳,等. 呼出气一氧化碳检测对支气管哮喘的诊断价值[J]. 中国呼吸与危重监护杂志, 2009,8(4):322–326.
[50]
沙莉,曹玲,马煜,等. 呼出气一氧化氮监测评估儿童哮喘病情临床价值研究[J]. 中国实用儿科杂志, 2011,26(4):264–268.
[51]
Rosi E , Ronchi MC , Grazzini M ,et al. Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: results of a factor analysis[J]. J Allergy Clin Immunol, 1999,103(2Pt 1):232–237.
[52]
Dweik RA , Boggs PB , Erzurum SC ,et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications[J]. Am J Respir Crit Care Med, 2011,184(5):602–615.
[53]
Dupont LJ , Demedts MG , Verleden GM . Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma[J]. Chest, 2003,123(3):751–756.
[54]
Schneider A , Tilemann L , Schermer ,et al. Diagnosing asthma in general practice with portable exhaled nitric oxide measurement--results of a prospective diagnostic study[J]. Respir Res, 2009,10:15.
[55]
Arora R , Thornblade CE , Dauby PA ,et al. Exhaled nitric oxide levels in military recruits with new onset asthma[J]. Allergy Asthma Proc, 2006,27(6):493–498.
[56]
Warke TJ , Fitch PS , Brown V ,et al. Exhaled nitric oxide correlates with airway eosinophils in childhood asthma[J]. Thorax, 2002,57(5):383–387.
[57]
Payne DN , Adcock IM , Wilson NM ,et al. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone[J]. Am J Respir Crit Care Med, 2001,164(8Pt 1):1376–1381.
[58]
Mattes J , Storm VGK , Reining U ,et al. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma[J]. Eur Respir J, 1999,13(6):1391–1395.
[59]
Jatakanon A , Lim S , Kharitonov SA ,et al. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma[J]. Thorax, 1998,53(2):91–95.
[60]
Jones SL , Kittelson J , Cowan JO ,et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control[J]. Am J Respir Crit Care Med, 2001,164(5):738–743.
[61]
Berry MA , Shaw DE , Green RH ,et al. The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma[J]. Clin Exp Allergy, 2005,35(9):1175–1179.
[62]
李瑞,赵海金,蔡绍曦,等. 支气管哮喘患者呼出气一氧化氮、肺功能、ACQ7评分之间的相关性研究[J]. 中华哮喘杂志(电子版), 2012(3):151–155.
[63]
龚颖,叶伶,安霞,等. 评估呼出气一氧化氮(FeNO)在支气管哮喘管理中的作用[J]. 复旦学报:医学版, 2013,40(3):349–353.
[64]
Strunk RC , Szefler SJ , Phillips BR ,et al. Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children[J]. J Allergy Clin Immunol, 2003,112(5):883–892.
[65]
Shaw DE , Berry MA , Thomas M ,et al. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial[J]. Am J Respir Crit Care Med, 2007,176(3):231–237.
[66]
Porsbjerg C , Lund TK , Pedersen L ,et al. Inflammatory subtypes in asthma are related to airway hyperresponsiveness to mannitol and exhaled NO[J]. J Asthma, 2009,46(6):606–612.
[67]
Westergaard CG , Munck C , Helby J ,et al. Predictors of neutrophilic airway inflammation in young smokers with asthma[J]. J Asthma, 2014,51(4):341–347.
[68]
Amelink M , de Groot JC , de Nijs SB ,et al. Severe adult-onset asthma: a distinct phenotype[J]. J Allergy Clin Immunol, 2013,132(2):336–341.
[69]
Silkoff PE , Lent AM , Busacker AA ,et al. Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma[J]. J Allergy Clin Immunol, 2005,116(6):1249–1255.
[70]
Szefler SJ , Martin RJ . Lessons learned from variation in response to therapy in clinical trials[J]. J Allergy Clin Immunol, 2010,125(2):285–294.
[71]
Smith AD , Cowan JO , Brassett KP ,et al. Exhaled nitric oxide: a predictor of steroid response[J]. Am J Respir Crit Care Med, 2005,172(4):453–459.
[72]
Szefler SJ , Martin RJ , King TS ,et al. Significant variability in response to inhaled corticosteroids for persistent asthma[J]. J Allergy Clin Immunol, 2002,109(3):410–418.
[73]
Knuffman JE , Sorkness CA , Lemanske RJ ,et al. Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma[J]. J Allergy Clin Immunol, 2009,123(2):411–416.
[74]
Anderson WJ , Short PM , Williamson PA ,et al. Inhaled corticosteroid dose response using domiciliary exhaled nitric oxide in persistent asthma: the FENO type trial[J]. Chest, 2012,142(6):1553–1561.
[75]
Nishio K , Odajima H , Motomura C ,et al. Effect of inhaled steroid therapy on exhaled nitric oxide and bronchial responsiveness in children with asthma[J]. J Asthma, 2006,43(10):739–743.
[76]
Jatakanon A , Lim S , Chung KF ,et al. An inhaled steroid improves markers of airway inflammation in patients with mild asthma[J]. Eur Respir J, 1998,12(5):1084–1088.
[77]
Taylor DR . Advances in the clinical applications of exhaled nitric oxide measurements[J]. J Breath Res, 2012,6(4):47102.
[78]
Cowan DC , Cowan JO , Palmay R ,et al. Effects of steroid therapy on inflammatory cell subtypes in asthma[J]. Thorax, 2010,65(5):384–390.
[79]
Plaza V , Ramos-Barbon D , Munoz AM ,et al. Exhaled nitric oxide fraction as an add-on to ACQ-7 for not well controlled asthma detection[J]. PLoS One, 2013,8(10):e77085.
[80]
Yoon JY , Woo SI , Kim H ,et al. Fractional exhaled nitric oxide and forced expiratory flow between 25% and 75% of vital capacity in children with controlled asthma[J]. Korean J Pediatr, 2012,55(9):330–336.
[81]
Kharitonov SA , Donnelly LE , Montuschi P ,et al. Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma[J]. Thorax, 2002,57(10):889–896.
[82]
Perez-De-Llano LA , Carballada F , Castro AO ,et al. Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma[J]. Eur Respir J, 2010,35(6):1221–1227.
[83]
Beck-Ripp J , Griese M , Arenz S ,et al. Changes of exhaled nitric oxide during steroid treatment of childhood asthma[J]. Eur Respir J, 2002,19(6):1015–1019.
[84]
Koster ES , Raaijmakers JA , Vijverberg SJ ,et al. Inhaled corticosteroid adherence in paediatric patients: the PACMAN cohort study[J]. Pharmacoepidemiol Drug Saf, 2011,20(10):1064–1072.
[85]
McNicholl DM , Stevenson M , McGarvey LP ,et al. The utility of fractional exhaled nitric oxide suppression in the identification of nonadherence in difficult asthma[J]. Am J Respir Crit Care Med, 2012,186(11):1102–1108.
[86]
中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗和管理方案)[J]. 中华结核和呼吸杂志, 2008,31(3):177–185.
[87]
Mario SR , Jose A , Castro R ,et al. Fractional exhaled nitric oxide has a good correlation with asthma control and lung function in latino children with asthma[J]. J Asthma, 2013,50(6):590–594.
[88]
Dweik RA , Sorkness RL , Wenzel S ,et al. Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma[J]. Am J Respir Crit Care Med, 2010,181(10):1033–1041.
[89]
Michils A , Baldassarre S , Van Muylem A . Exhaled nitric oxide and asthma control:a longitudinal study in unselected patients[J]. Eur Respir J, 2008,31(3):539–546.
[90]
Zeiger RS , Schatz M , Zhang F ,et al. Elevated exhaled nitric oxide is a clinical indicator of future uncontrolled asthma in asthmatic patients on inhaled corticosteroids[J]. J Allergy Clin Immunol, 2011,128(2):412–414.
[91]
Gelb AF , Flynn Taylor C , Shinar CM ,et al. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics[J]. Chest, 2006,129(6):1492–1499.
[92]
Jayaram L , Pizzichini MM , Cook RJ ,et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations[J]. Eur Respir J, 2006,27(3):483–494.
[93]
Smith AD , Cowan JO , Brassett KP ,et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma[J]. N Engl J Med, 2005,352(21):2163–2173.
[94]
Pijnenburg MW , Bakker EM , Hop WC ,et al. Titrating steroids on exhaled nitric oxide in children with asthma:a randomized controlled trial[J]. Am J Respir Crit Care Med, 2005,172(7):831–836.
[95]
Donohue JF , Jain N . Exhaled nitric oxide to predict corticosteroid responsiveness and reduce asthma exacerbation rates[J]. Res Med, 2013,107(7):943–952.
[96]
Mahr TA , Malka J , Spahn JD . Inflammometry in pediatric asthma: a review of fractional exhaled nitric oxide in clinical practice[J]. Allergy Asthma Proc, 2013,34(3):210–219
[97]
Powell H , Murphy VE , Taylor DR ,et al,Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial[J]. Lancet, 2011,378(9795):983–990.
[98]
Szefler SJ , Mitchell H , Sorkness ,et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomized controlled trial[J]. Lancet, 2008,372(9643):1065–1672.
[99]
de Jongste JC , Carraro S , Hop WC ,et al. Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma[J]. Am J Respir Crit Care Med, 2009,179(2):93–97.
[100]
Gibson PG . Using fractional exhaled nitric oxide to guide asthma therapy: design and methodological issues for asthma treatment algorithm studies[J]. Clin Exp Allergy, 2009,39(4):478–490.
[101]
Pijnenburg MW , Hofhuis W , Hop WC ,et al. Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission[J]. Thorax, 2005,60(3):215–218.
[102]
Zacharasiewicz A , Wilson N , Lex C ,et al. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children[J]. Am J Respir Crit Care Med, 2005,171(10):1077–1082.
备注信息
A
林江涛,100029北京,中日友好医院呼吸内科,Email:
tendef.3ab62l_oatgnaij
评论 (0条)
注册 登录
时间排序
- 时间排序
暂无评论,发表第一条评论抢沙发
最新推荐
更多
D-二聚体实验室检测与临床应用中国专家共识
中国研究型医院学会血栓与止血专业委员会 中华医学杂志 2023,103(35)
B型利钠肽及N末端B型利钠肽前体实验室检测与临床应用中国专家共识
中国医师协会检验医师分会心血管专家委员会 中华医学杂志 2022,102(35)
能量CT临床应用中国专家共识
中华医学会放射学分会 等 中华放射学杂志 2022,56(05)
心肌肌钙蛋白实验室检测与临床应用中国专家共识
中国医师协会检验医师分会心血管专家委员会 中华医学杂志 2021,101(37)
分享
详细信息
表
访问与引文
阅读权限
参考文献
访问与引用
访问数据
0
0
全部时间 最近30天 最近6个月 最近12个月
MedAI助手(体验版)
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照
文献快照
N/A
N/A
AI总结中

N/A
N/A
快照内容由人工智能生成,供您参考。

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。
0/50
很抱歉,当前对话已达到其限制。
使用"新建对话"按钮开启更多对话。
停止回答
0/2000
信息反馈
中文(简体)
英文
翻译
机器翻译功能由科大讯飞提供技术支持
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。

你好! 今天我能为您提供什么帮助?
0/30
of
很抱歉,当前对话已达到其限制。
使用"新建对话"按钮开启更多对话。
停止回答
扩写 缩写 改写 翻译
0/2000
信息反馈
历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号
小中大
翻译
润色
扩写
缩写
复制
引用